Market research

4887.TSE Sawai Group Holdings Co., Ltd

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 183B
P/E ratio: 15.88
Analyst target: 2182.2222
Dividend yield: 3.4%
Beta: 0.03

Loading price history…

Profile

Company facts

Exchange: TSE
Currency: JPY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
ISIN: JP3323040000
Market cap: 183B
P/E ratio: 15.88
Analyst target: 2182.2222
Dividend yield: 3.4%
Beta: 0.03

About

About Sawai Group Holdings Co., Ltd

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals. The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others. It sells its generic drugs through distributors, wholesalers, and retailers. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about 4887.TSE.

4887.TSE Sawai Group Holdings Co., Ltd

Price & volume

Company facts

About Sawai Group Holdings Co., Ltd

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet